Russia Rejects Bioweapons Talk in U.S. Congress as ‘Propaganda’

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
May 13, 2014, 8:31 a.m.

Rus­sia ac­cused U.S. law­makers of host­ing “a pro­pa­ganda event” last week to ex­am­ine its bio­lo­gic­al-weapons po­ten­tial, In­ter­fax re­ports.

The Rus­si­an for­eign min­istry dis­missed as­ser­tions in May 7 con­gres­sion­al testi­mony that Mo­scow may con­tin­ue to over­see a bio­lo­gic­al-arms pro­gram. The min­istry blamed the United States for the ab­sence of a mon­it­or­ing sys­tem un­der the Bio­lo­gic­al Weapons Con­ven­tion, which pro­hib­its mem­ber na­tions from de­vel­op­ing, man­u­fac­tur­ing or pos­sess­ing bio­lo­gic­al ma­ter­i­als for use in com­bat.

“Rus­sia sup­ports con­sist­ently en­han­cing [the treaty] by draft­ing and passing an ad­di­tion­al leg­ally bind­ing pro­tocol stip­u­lat­ing, among oth­er things, nondis­crim­in­at­ory and ef­fi­cient veri­fic­a­tion meas­ures,” the min­istry ar­gued in pre­pared com­ments.

The United States uni­lat­er­ally cut short a dec­ade of “sig­ni­fic­ant work” by treaty sig­nat­or­ies to es­tab­lish veri­fic­a­tion pro­ced­ures, and since that time has re­mained stead­fast in its op­pos­i­tion to a mon­it­or­ing re­gime, the Rus­si­an of­fice stated.

Rus­sia is­sued the re­marks in re­ac­tion to a hear­ing of the House For­eign Af­fairs Sub­com­mit­tee on Europe, where Uni­versity of Mary­land seni­or schol­ar Milton Leiten­berg said the ex­ist­ence of a Rus­si­an bio­lo­gic­al-arms pro­gram can­not be ruled out be­cause Mo­scow does not per­mit out­side ac­cess to key fa­cil­it­ies of con­cern.

Ac­cord­ing to the min­istry, “It is sur­pris­ing that cer­tain rep­res­ent­at­ives of the U.S. es­tab­lish­ment con­tin­ue de­mand­ing uni­lat­er­al ac­cess to the Rus­si­an bio­lo­gic­al fa­cil­it­ies amid the U.S. re­fus­al from such a fair and clear [veri­fic­a­tion] mech­an­ism. Such de­mands are in­ap­pro­pri­ate and un­ac­cept­able.”

The for­eign of­fice ad­ded that par­ti­cipants in the con­gres­sion­al hear­ing mis­in­ter­preted a 2012 art­icle in which Rus­si­an Pres­id­ent Vladi­mir Putin said “ge­net­ic” tech­no­lo­gies could pave the way for more soph­ist­ic­ated bio­lo­gic­al arms.

The lead­er sug­ges­ted that such tech­niques “could be used abroad,” but the “thought was turned up­side down at the hear­ing in the Con­gress,” the Rus­si­an min­istry said.

What We're Following See More »
MEETING WITH SENATE GOP
Trump to Hill Next Tuesday
45 minutes ago
THE DETAILS
INTERPARTY FEUDING CONTINUES UNDER PEREZ
Longtime Progressive Members Pushed Out at DNC
1 hours ago
THE LATEST

"A shake-up is underway at the Democratic National Committee as several key longtime officials have lost their posts, exposing a still-raw rift in the party and igniting anger among those in its progressive wing who see retaliation for their opposition to DNC Chairman Tom Perez. The ousters come ahead of the DNC's first meeting, in Las Vegas, Nevada, since Perez took over as chairman with a pledge this year to unite a party that had become badly divided during the brutal Bernie Sanders-Hillary Clinton 2016 primary race."

Source:
LAST-DITCH FOR A FEW, SPECIFIC CASES
FDA Approves Personalized Cancer Therapy
3 hours ago
THE DETAILS
WILL RESIGN BY JAN. 31
Rep. Tiberi Confirms Resignation Report
4 hours ago
THE DETAILS

In a statement, Rep. Pat Tiberi (R-OH 12) confirmed a New York Times report that he would resign to lead the Ohio Business Roundtable. "While I have not yet determined a final resignation date, I will be leaving Congress by January 31, 2018."

Source:
AID DROPPED TO 222,000
Unemployment Claims Fall to Lowest in 44 Years
4 hours ago
THE DETAILS

"The number of Americans collecting unemployment benefits fell last week to the lowest level" since March 1973. According to the Labor Department Thursday, "claims for jobless aid dropped by 22,000 to 222,000." Additionally, "the less volatile four-week average slid by 9,500 to 248,250, lowest since late August."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login